Le Lézard
Classified in: Health, Science and technology
Subject: PLW

Feldan Therapeutics awarded US Patent for the second generation of its Feldan Shuttle platform


QUEBEC CITY, May 29, 2018 /PRNewswire/ - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a peptide-based delivery method which allows the introduction of foreign proteins, peptides or genome-editing nucleases inside cells, is applicable to the development of new therapies.

The United States Patent and Trademark Office (USPTO) granted Feldan Therapeutics the U.S. Patent No. 9982267, on May 29, 2018. The latter will provide the rationally designed generation of the Feldan Shuttle technology with a strong and broad protection, in addition to further strengthening the company's patent portfolio. The new generation of Shuttles, based on entirely in-house engineered sequences, is designed to have higher delivery efficiency and improved cell viability.

"The issuance of our second patent is the result of outstanding work and innovative potential carried out by Feldan's team, said Francois-Thomas Michaud, PhD. eng., Chief Executive Officer of Feldan Therapeutics. This demonstrates constant commitment toward creating more value for our stakeholders and fulfilling our mission to develop breakthrough therapeutic applications."

About Feldan Therapeutics

Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery of various proteins including CRISPR nucleases, transcription factors and antibodies. The platform has been successfully used in both ex vivo and in vivo applications. Feldan Therapeutics's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.

For further information: www.feldan.com

 

SOURCE Feldan Therapeutics


These press releases may also interest you

at 15:11
The technology service provider market is at a crucial turning point, marked by exponential technological innovation,...

at 15:10
ServiceChannel, the leading platform for the procurement and delivery of facilities services, announced today the introduction of new solutions that empower business operators to maximize their facilities investments. The Spring 2024 Product...

at 15:05
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent directors Cristian Luput and Ramiro Guerrero, J.D, LL.M. made individual...

at 15:01
G FUEL and Gearbox Entertainment Company celebrate gaming icon Duke Nukem with Ego Boost, a new zero-sugar Energy Formula now available at GFUEL.com. Fans can purchase the cherry, orange, and pomegranate flavor as a 40-serving standalone powder Tub...

at 15:00
Beghou Consulting announced Thursday several additions to its executive team to support the company's technology innovation, product development and growth initiatives. Dan Cardinal, a Partner at Beghou, will become Chief Technology Officer. The...

at 15:00
Certified BERNINA dealer, Hoover's BERNINA Sew LLC, is thrilled to announce the return of their annual Spring Fling event. Taking place April 10th through April 12th at The Rusty Rail, the event offers giveaways, door prizes, and the opportunity to...



News published on and distributed by: